Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
Patients with Advanced Cancer May Benefit from Discussing Prognosis with PhysiciansPatients with advanced cancer may benefit from having discussions about their prognoses with their physicians.
-
Study Identifies New Opportunities for Targeted ImmunotherapyA team of NCI researchers has reported that several types of gastrointestinal cancer have tumor-specific mutations that can be recognized by the immune system, thereby offering a new therapeutic opportunity for patients with these tumors.
-
In Triple-Negative Breast Cancer, Targeting an AddictionA new approach to disrupting genes that promote the development and spread of tumors may hold promise for treating an aggressive and difficult-to-treat type of breast cancer.
-
Bringing Cancer Research to the Public: NCI’s Networks and ProgramsA number of NCI programs and networks are the foundation of the National Cancer Program and play a critical role in promoting progress.
-
Long-Term Study Finds No Increased Risk of Miscarriage after HPV VaccinationWomen in a clinical trial who became pregnant after vaccination with a bivalent human papillomavirus (HPV) vaccine did not have an increased risk of miscarriage.
-
FDA Approves Combination Drug for Patients with Advanced Colorectal CancerThe FDA has approved a single drug that combines trifluridine and tipiracil to treat patients with metastatic colorectal cancer whose disease progressed after standard treatment.
-
Progress against Cancer: The Role of Basic ScienceActing NCI Director Doug Lowy, M.D., discusses the critical contribution of basic science in fostering progress against cancer.
-
TCGA Wins 2015 Sammies People’s Choice AwardThe Partnership for Public Service presented the 2015 People’s Choice Award to the government staff and researchers who have worked on The Cancer Genome Atlas.
-
NCI’s Steven Rosenberg Wins Service to America MedalThe Partnership for Public Service has awarded Steven A. Rosenberg, M.D., of NCI's Center for Cancer Research, with its highest 2015 Samuel J. Heyman Service to America Medal, or Sammie.
-
Persistence of Genetic Mutations after Chemotherapy Linked to Poor Outcomes in Some Patients with AMLThe persistence of genetic mutations in some patients with acute myeloid leukemia may allow physicians to better classify their risk of recurrence.
-
"Fine Tuning" Engineered T Cells May Extend Immunotherapy Approach to More Cancer TypesEngineering immune cells to have a decreased affinity for their targets on cancer cells may not weaken their efficacy but may reduce the risk of side effects.
-
Cancer Trends: Influencing Care and Research PrioritiesMany of the trends being seen in cancer are changing how we view cancer and how we address it, from prompting research to identify the underlying causes of cancers increasing in incidence to informing research on treatment and prevention.
-
CPTAC, the Complementary Sibling of TCGA: An Interview with Dr. Henry Rodriguez about NCI’s Proteomics ProgramDr. Henry Rodriguez explains the goals and future directions of CPTAC, a collaborative consortium of institutions and investigators who study cancer proteomics.
-
For Some Children with Cancer, Genomic Information May Help Guide Treatment DecisionsGenomic methods, such as DNA sequencing, may help doctors manage the treatment of children and young adults with cancer.
-
NCI Releases Budget Proposal for Fiscal Year 2017The NCI Annual Plan and Budget Proposal for Fiscal Year 2017 provides an overview of NCI’s priorities and key initiatives and the institute’s funding request.
-
FDA Approves Rolapitant to Prevent Nausea and Vomiting from ChemotherapyThe FDA has approved rolapitant to prevent chemotherapy-induced nausea and vomiting.
-
NCI Initiative to Speed Development of Childhood Cancer TherapiesNCI has awarded grants to five research teams to participate in its Pediatric Preclinical Testing Consortium, which is intended to help to prioritize which agents to pursue in pediatric clinical trials.
-
Intraperitoneal Chemotherapy in Advanced Ovarian Cancer Improves Survival, But Is UnderusedUse of intraperitoneal chemotherapy, along with intravenous chemotherapy, improves survival in some women with advanced ovarian cancer, but its use in clinical practice has been limited, according to a new study.
-
FDA Approves Sonidegib for Some Patients with Advanced Basal Cell CarcinomaThe FDA has approved sonidegib for the treatment of patients with locally advanced basal cell carcinoma.
-
Cancer Risk in Childhood Cancer Survivors Continues for DecadesSurvivors of childhood cancer have an elevated risk of developing second, distinct cancers into their forties and beyond, according to a new study.